Sort by
Keyphrases
Cancer Outcomes
100%
Surveillance Program
100%
Bladder Cancer
100%
Molecular Alterations
100%
Cancer Surveillance
100%
Smoking Intensity
100%
E-cadherin
66%
Apoptotic Protease Activating factor-1
50%
Multivariable
33%
Clinical Outcomes
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Worse Outcome
16%
Cancer Patients
16%
Common Risk Factors
16%
Prognostic Value
16%
Predictive Value
16%
All Diseases
16%
Adjuvant Therapy
16%
Caspase-3
16%
Vascular Endothelial Growth Factor
16%
Multivariable Model
16%
Pathological Stage
16%
Disease Stage
16%
Cyclooxygenase-2
16%
Bladder Tumor
16%
Major Risk Factors
16%
Prognosis Prediction
16%
Molecular Profiling
16%
Multimarker
16%
Surgical Modality
16%
Biomarker Panel
16%
Population-based Cohort
16%
Cancer Registry
16%
Developing World
16%
Surgical Adjuvants
16%
Single Marker
16%
Daily Frequency
16%
Medicine and Dentistry
Biological Marker
100%
Uvomorulin
100%
Bladder Cancer
100%
Cancer Epidemiology
100%
Protein P53
75%
Apoptotic Protease Activating Factor 1
75%
Cancer Registry
25%
Vasculotropin
25%
Adjuvant Therapy
25%
P21
25%
Caspase 3
25%
Bladder Tumor
25%
Cyclooxygenase 2
25%
Patient Registry
25%
Molecular Profiling
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Bladder Cancer
100%
Cancer Epidemiology
100%
Uvomorulin
100%
Protein P53
75%
Apoptotic Protease Activating Factor 1
75%
Caspase 3
25%
Vasculotropin
25%
Cyclooxygenase 2
25%
Cancer Registry
25%
Bladder Tumor
25%
Diseases
25%
Biochemistry, Genetics and Molecular Biology
Cadherin
100%
P53
75%
Apoptotic Protease Activating Factor
75%
Fibrinogen
75%
Cyclooxygenase
25%
Caspase 3
25%
Vascular Endothelial Growth Factor
25%
P21
25%
Bcl-2
25%
Cancer Registry
25%
Food Science
Cadherin
100%
Cyclooxygenase
25%